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Abstract: Here we present a new generic opto-bio-sensing platform combining immobilised 
aptamers on an infrared plasmonic sensing device generated by nano-structured thin film that 
demonstrates amongst the highest index spectral sensitivities of any optical fibre sensor 
yielding on average 3.4 × 104 nm/RIU in the aqueous index regime (with a figure of merit of 
330) This offers a single stage, solution phase, atto-molar detection capability, whilst 
delivering real-time data for kinetic studies in water-based chemistry. The sensing platform is 
based upon optical fibre and has the potential to be multiplexed and used in remote sensing 
applications. As an example of the highly versatile capabilities of aptamer based detection 
using our platform, purified thrombin is detected down to 50 attomolar concentration using a 
volume of 1mm3 of solution without the use of any form of enhancement technique. 
Moreover, the device can detect nanomolar levels of thrombin in a flow cell, in the presence 
of 4.5% w/v albumin solution. These results are important, covering all concentrations in the 
human thrombin generation curve, including the problematic initial phase. Finally, selectivity 
is confirmed using complementary and non-complementary DNA sequences that yield 
performances similar to those obtained with thrombin. 
©2016 Optical Society of America 
OCIS codes: (240.6680) Surface plasmons; (060.2370) Fiber optics sensors; (220.4241) Nanostructure fabrication; 
(280.4788) Optical sensing and sensors; (280.1415) Biological sensing and sensors. 
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1. Introduction 
Progress in biotechnology demands sensing platforms that can be readily combined with the 
specific and selective binding of target molecules by the inclusion of affinity reagents, such 
as aptamers, antibodies and other antibody mimetics. Aptamers (specific, single-stranded 
DNA oligonucleotides) are attractive affinity reagents and are potential antibody 
replacements for the development of biomolecular nanosensors owing to their high affinity, 
specificity, in-vitro synthesis and stability [1, 2]. Aptamers are analogous to antibodies with 
respect to the variety of substances they can detect and their range of applications, but they 
have some distinct advantages [3]. One is their greater specificity and affinity [4], while 
others include their ability to tolerate a larger range of pH environments and temperature 
variations [3], with aptamers being more stable than antibodies. Moreover, aptamers have a 
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greater shelf life than antibodies. The development of nucleic acid based aptamers and 
research into their potential applications has gathered pace since their inception in 1990 [1]. 
These single-stranded short oligonucleotides form three-dimensional structures that bind to 
their target molecule with high affinity and specificity. As the oligonucleotides are short (15-
60 bp) they can be routinely and reproducibly synthesised chemically. The development of 
aptamers with affinity for a diverse range of biological targets has led to their employment 
not only in diagnostics but also in clinical/therapeutic [5] applications and as the affinity 
reagents in cell specific drug delivery [6]. 
Of particular interest is the serine protease thrombin, which is crucial to clot formation 
and the blood coagulation process and is also important in anticoagulation, wound healing, 
chemotaxis and inflammatory responses [7]. Due to its important and diverse biological roles, 
thrombin was one of the initial targets for aptamer development [8]. As such, a wealth of 
literature characterizes not only the thrombin aptamer interaction, but also the use of such 
aptamers in thrombin quantification. Fibre optic evanescent wave sensors based upon 
fluorescent coagulation [9] and surface plasmon resonance (SPR) sensors [10–12], have been 
developed recently. These have been used to detect other biochemical compounds by 
utilising immobilized bio-recognition molecular coatings on a metallic surface. 
SPR is an important optical phenomenon that involves the resonant transfer of incident 
propagating light to surface-plasmon modes that take the form of collective electron 
oscillations in a metal [13]. Sensors exploiting SPR can be divided into three types based 
upon the kind of surface plasmon being generated at the metal/dielectric interface: long range 
surface plasmons (LRSP) [14], short range surface plasmons (SRSP) [15] and localised 
surface plasmons (LSP) [16]. SPR biosensors offer the opportunity for real-time and label-
free monitoring of biomolecular interactions [17]. The plasmons exist at a metal–dielectric 
interface and depending on the topology of the supporting metal coating the dispersion 
relation can change [16]; the LRSP and SRSP obey the same dispersion relationship, whereas 
localised surface plasmons have a strong dependence on the surface structure [18]. 
We have previously reported some initial, modest experimental results of plasmonic fibre 
sensors [11] working in conjunction with aptamers that have shown potential as an optical 
chemical sensing platform. . SPR-based DNA sensing has previously achieved sensitivities 
down to femto and even atto-molar concentrations utilising enhancement amplification 
techniques [19–21], however these enhancement techniques at best complicate the binding 
mechanism with the inclusion of additional particles [22] and thus modify and compromise 
the binding kinetics. 
The authors here report for the first time an optical biosensing platform working with an 
immobilised aptamer that is able to detect attomolar concentrations of thrombin directly, 
without any further enhancement techniques (in a sample volume of 1mm3). The foundation 
upon which these results are based is an optical sensing platform utilizing surface plasmons 
resonances and offering spectral sensitivity to refractive index in excess of 3.4×104 nm/ RIU, 
leading to a conservative detection limit of 2.0 × 10−6 with a F.O.M. of 330 in the aqueous 
index regime for the sensing platform. This spectral index sensitivity is the highest reported 
in the literature [23–25] and leads to one of the highest index resolutions [23–25]. This result 
not only represents a 2 to 3 orders of magnitude improvement in detection limit over previous 
reports [26], but is also in the same range as those employing additional enhancement 
amplification techniques. The experimental data presented in this paper show the system is 
capable of monitoring in the solution phase and in real-time the binding of the aptamer to the 
target molecule without any additional species being involved, giving experimentalists the 
opportunity to study binding kinetics without the added complexity of an enhancement 
technique 
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2. Fabrication and characterisation of bio-sensing platform 
2.1 Optical sensing platform fabrication 
For ease of interrogation an optical fibre platform was used for the devices, as has previously 
been described [27]. The devices were processed in three stages, resulting in a D-shaped fibre 
with nano-structured multi-layered coatings. The multi-layered coatings consisted of three 
different materials: germanium (48nm), silicon dioxide (48nm) and gold (38nm). The nano-
structuring consisted of surface corrugations with dominant structured spatial periods close to 
0.5μm, 1μm, 2μm and 4μm, see schematic Fig. 1(a) and 1(b). 
In brief, a lapped region of the fibre is coated sequentially with three materials; firstly 
germanium is deposited upon the lapped fibre followed by silicon dioxide and finally gold 
(Au-SiO2-Ge/fibre). The nano-structuring of this coating is created by utilising the 
photobleaching effect that UV laser light has on germanium oxides, found in the multi-
layered coating; the UV light produces a change in the optical properties (refractive index) 
and generates material compaction (a geometrical structural change [27]). This second effect 
is used to generate the nano-structure (array of nano-wires) of the coating. The UV irradiance 
pattern is generated by a phase mask, producing a diffraction pattern that is conventionally 
used to produce fibre Bragg gratings. The UV irradiance is produced using an argon ion laser 
(Innova® Sabre® FRED) operating at 244nm. 
Typical fabrication parameters used are a scanning velocity of 0.05mms−1 and a UV 
optical power on the fibre itself of approximately 120mW. The equipment and alignment 
used for producing conventional fibre Bragg gratings is used to create the nanostructured 
coated D-shaped fibres. A typical period of a phase mask used in this process is 1.072 μm 
and a typical surface topology created by this procedure is shown in Fig. 1(c) along with a 
schematic of the sensing evanescent field. The surface topologies have been characterised 
physically and chemically using an atomic force microscope (Park Scientific Instruments 
AutoProbe, Thermomicroscopes) (AFM) and X-ray Photoelectron Spectroscopy, (Thermo 
Fisher ESCALAB 250 Imaging XPS Instrument, spatial resolution 10nm) XPS. It was found 
that the resultant surface topology was characterised by regions having corrugation and the 
XPS revealed that the apexes of the surface ridges were metal surrounded by dielectric 
material. This creates an array of parallel nanowires perpendicular to the central axis of the 
optical fibre, see Figs. 1(c) and 1(d). The total length of the array depends upon the lapped 
region of the fibre, the length of the phase mask used and the scanning length of UV 
irradiance; typically the total length of the array is approximately 2.2cm. The nominal 
dimensions of a single corrugation are as follows: approximate length 20 μm (perpendicular 
to the optical fibre central axis), with the individual apex of the corrugation having an 
average FWHM 180nm ± 20 nm. Figure 1(e), shows a cross-section line profile for a few 
corrugations. Furthermore, closer inspection of Fig. 1(c) shows the UV processed region and 
pristine areas that are flat. Performing a Fast Fourier Transform on the AFM scan showed we 
have various spatial periods present with the predominant period being approximately half 
the phase mask period. The particular example yields periods of 0.348μm, 0.512μm and 
1.087μm, see Fig. 1(f). A higher resolution AFM scan revealed fine surface structures within 
a single nano-antenna, this appears to be due to the fact the phase mask produces a 3-
dimensional interference pattern, see Fig. 1(d). These arrays support localised surface 
plasmons [27]. 
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Fig. 1. (a) Schematic representation of the multi-layered and nanoscale structured coating that 
supports the localised surface plasmons (b) Representation of the structured thin film coating 
created after the various stages of processing. (c) An example of an AFM image of the sensing 
region on the flat of the D-shaped fibre showing the surface corrugation after UV processing 
and a pristine surface. (d) An example of AFM image showing the fine structure within 
several nano-antennas. (e) Typical experimental data of the height variation across several 
nano-antennas. (f) A typical FFT of the cross-section along the nano-antenna array that is 
along the optical fibre axis and perpendicular to a single nano-antenna. 
The devices were characterised by measuring changes in their response as a function of 
the azimuthal polarisation properties of the illuminating light and of the surrounding 
medium’s refractive index. For the latter experiments, the fibres were placed in a V-groove 
and immersed in certified refractive index liquids that have a quoted accuracy of ± 0.0002, 
Fig. 2(a). The V-groove was made in an aluminium plate, machined flat to minimise bending 
of the fibre. The plate was placed on an optical table, which acted as a heat sink to help 
maintain a constant temperature throughout the experiments. 
2.2 Optical detection scheme 
Light from a broadband light source, was passed through a polariser and a polarisation 
controller before illuminating the sample, with the transmission spectrum being monitored 
using an optical spectrum analyser. The change in polarisation of the illuminating light was 
monitored with a polarimeter (Tektronix, PAT 9000B) through a polarisation maintaining 
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coupler, see Fig. 2(a). Due to the spectral broadness of the surface plasmon transmission 
features that are used to measure the concentration changes, the central wavelengths were 
calculated by using the first moment of the power spectrums; i.e. the centroid by geometric 
decomposition [28]. The associated transmission centroid strength value of the SPR was 
obtained as the mean value over the range where the extinction transmission feature is greater 
than 6dB level in attenuation. 
2.3 Aptamer thrombin assay procedure 
Prepared fibres were coated with a thrombin aptamer 5′ – SH(CH2)6 - GGT TGG TGT GGT 
TGG - 3′ [29, 30]. The aptamer was immobilised to the fibre by a thiol mediated linkage. 
Fibres were stored in potassium phosphate buffer (100mM pH7.4). Alpha thrombin from 
human plasma was obtained from Sigma (Sigma T6884). Binding buffer (50mM Tris 
140mM NaCl 1mM MgCl2) pH 7.4, was used for all binding experiments. The BSA was 
supplied by Sigma-Aldrich product A9418. 
2.4. Detection of thrombin 
Thrombin solutions ranging from concentrations of 5aM to 1µM were prepared in a binding 
buffer by performing serial logarithmic dilutions on ice (to prevent de-naturation of the 
thrombin). The sensor was used in two different experiments; firstly, using a fixed volume of 
solution of thrombin, the sensor being exposed to the solutions lying in a flat aluminium v-
groove. After each thrombin solution was used the v-groove and the sensors were washed in 
a 4 molar solution of NaCl to regenerate the sensors and further washed in 50 mM Tris 
binding buffer solution (pH 7.4). The apparatus used in these experiments are shown Fig. 
1(a). The second experiment used a flow sample cell attached to a syringe driver to deliver a 
constant flow rate of a given solution, Fig. 2(b). Both sets of experiments consisted of two 
separate tests. The first was the detection of various concentrations of thrombin dissolved in 
buffer solution (50 mM Tris 140 mM NaCl 1 mM MgCl2) pH 7.4, using both a fixed volume 
and a flow sample cell used with a flow rate of 5 μl/min. The second involved a repeat of 
these same experiments with the same concentrations of thrombin but in bovine serum 
albumin (BSA) at a concentration of 4.5% w/v, dissolved in a 50 mM Tris buffer solution 
(pH 7.4), which provides very similar test condition to samples from human beings. 
Fig. 2. Scheme used for the characterisation of the devices and the detection of the thrombin in 
ultra-low concentration solutions, (a) schematic of experimental apparatus used for fixed 
volumes of thrombin solutions and equipment to optimise the polarisation of the illuminating 
light to obtain a LSP resonance with maximum optical strength in the transmission spectra, (b) 
image of the sample cell used for constant solution flow experiments. 
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3. Experimental results for optical sensing platform and biosensor
3.1 Optical sensing platform spectral behavior and performance 
After the bare fibres are lapped, their spectral index and polarisation sensitivities are 
measured to ensure that the core of the fibre is not exposed and that there is enough optical 
dynamic range,so that the surface plasmon resonances in transmission can be fully measured. 
The highest refractive index solution used on the bare fibres is 1.448, because this is 
approximately the refractive index of the cladding, thus effectively removing the 
cladding/surrounding medium interface. Figures 3(a)-3(b) show a typical spectral index 
response and sensitivity of the bare D-shaped fibre. On inspection the individual spectra 
display a reasonably flat wavelength response with increasing index, up to the highest 
refractive index (1.448), displaying an average optical power loss of approximately 7 dB 
from air, with a device loss of ~1.8dB, see Fig. 3(b). The optical power losses as a function of 
polarisation were also investigated from an initial arbitrary polarisation state, this revealed 
that the average optical power varied by ± 1 dB, see Fig. 3(c). Furthermore, there appears to 
be an asymmetric variation in the response to polarisation and this is due to the initial 
arbitrary starting-point. 
Fig. 3. The spectral characterisation of the bare D-shaped fibre before coating and UV 
processing (a) the response of transmission spectra with increasing refractive index. (b) The 
average optical attenuation losses over the spectral range of 1250nm to 1690nm. (c) The 
variation of the average optical attenuation losses as a function of azimuthal polarisation 
measured from an initial, arbitrary polarisation state. 
After the array of nano-wires is produced on the D-shaped fibres and before the 
immobilisation of the thrombin aptamer, the spectral characteristics were again investigated 
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with regard to changes in the refractive index of the surrounding medium and the light 
polarisation. A schematic of the apparatus to investigate the spectral behaviour is shown in 
Fig. 2(a) and described further in the method section. Figure 4(a) and Fig. 4(b) shows the 
polarisation dependence of these devices and Fig. 5 shows the typical transmission spectral 
variation with changes in surrounding refractive index. 
Fig. 4. The polarisation dependence of the optical sensing platform (Au-SiO2-Ge/fibre) before 
aptamer immobilisation: (a) an example of the spectral dependence upon polarisation (b) The 
Stokes parameters of the illuminating light of resonances across the spectral range of interest 
(c) the typical azimuthal polarisation dependence of a localised surface plasmon in air. 
Figure 4(a) illustrates that a single device can generate surface plasmon resonances of 
comparable strength over the available light source wavelength range, using all possible 
polarisation states of the illuminating light. For completeness of investigation we measured 
the degree of polarisation of the illuminating light used to produce the series of surface 
plasmon resonances over the spectral range of interest; 1280nm to 1690nm. The Stokes 
parameters were measured using an in-line polarimeter (General Photonics, Polarisation 
Analyser, POD-201) and the results are shown in Fig. 4(b). It was found that the percentage 
of the “Degree of Polarisation” varied linearly as a function of wavelength from 96.8% to 
87.6% from the lower to higher wavelengths, respectively. The greatest variation occurring is 
with the azimuth of polarisation from 58.3 to 23.5 degrees, this doesn’t appear to be linear 
with spectral location of the resonance. The Stokes parameter S1 implies the light is linearly 
polarised, with both positive and negative values. These results are showing variations from 
horizontal to vertical linearly polarisation, which is expected due to the experimental set-up. 
The Stokes parameter S2 seems to be varying from 0.7 to 0.9; S2 is associated with angled 
linearly polarised and S3 has positive values which is associated with right-handed circularly 
polarised light. The S2 and S3 parameters are suggesting different surface topological features 
are associated with the different transmission resonances. 
There are several reasons for this spectral tunability: the plasmons exist at a metal–
dielectric interface and depending on the topology of the supporting metal coating the 
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dispersion relation can change [16]; the LRSP and SRSP obey the following dispersion 
relation for two homogeneous semi-infinite media: 
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where k is the free space wave number, εm is the dielectric constant of the metal (εm = εmr + i 
εmi) and ns is the refractive index of the dielectric sample to be tested. A corrugated nano 
structure can be considered as an array of apertures [31], with the momentum component of 
light parallel 2 22xk i jp
p
= ⋅ +  to the surface, where p is a lattice constant (the distance 
between the apertures), i and j are nonzero integer numbers, representing the scattering orders 
from the two dimensional aperture arrays. The resonant condition for the localised surface 
plasmons that needs to be satisfied for a lattice structure is given by [18]. From the FFTs of a 
typical UV processed surface shown in Fig. 1(c) and Fig. 1(d) there are a few potential lattice 
constants from primary structure of the nano-wire/nano-antenna array and from an individual 
nano-antenna. 
The tunability is increased by the imperfections in the fabrication process (such as 
misalignment of the D-shaped fibre, the variations in the focusing of the UV light, variations 
in the alignment of the phase mask to the fibre and UV light intensity) causing a variation in 
the nanowires’ shapes, size, geometries and composition, which would yield a variation in 
the phase matching condition for the excitation of resonances and spectrally broaden the 
resonances and implies short propagation lengths [32], which are observed experimental 
Furthermore, the spectral features have large tunability and vary in coupling strength as a 
function of polarization, and this indicates the presence of localized surface plasmons, instead 
of surface plasmons having short propagation lengths on rough surfaces that would produce 
reasonable resonance coupling over the azimuthal polarisation range from 0° to 180°. This 
fact along with the high polarisation sensitivity of 2.7dB/degree at the maximum strength of 
the excitation resonances shown in Fig. 4(b), indicates that the optical sensing platform is 
generating localised surface plasmons (LSPR). 
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Fig. 5. (a) The spectral transmission characteristics of the device (Au-SiO2-Ge/fibre) as a 
function of the index of the surrounding medium and (b) the spectral wavelength shift vs 
index. (c) The optical strength as a function of surrounding refractive index before aptamer 
immobilisation. (d) The transmission spectrum of the device after immobilisation of the 
thrombin aptamer when submerged in a buffer solution. 
Inspecting the results for the resonance wavelength dependence on surrounding index, 
Figs. 5(a)-5(d) reveals a maximum bulk refractive index sensitivity of Δλ/Δn of 1.7 × 104 nm/ 
RIU in the aqueous index regime, which yields a refractive index resolution of 5.9 × 10−6 and 
a Figure-of-Merit (FOM) of 210, determined using a standard approach [10, 17, 33–36] 
defined as FOM = (Δλ/Δn)/ΔλFWHM, where ΔλFWHM is the full width at half maximum of the 
spectral feature. The index resolution is determined in part by the utilized interrogation 
scheme, which in this case is an optical spectrum analyser (OSA) that has 1000 measurable 
points over the FWHM of the resonance (80nm), leading to measurable resolution of 0.08nm 
(greater than the resolution of the OSA). The peak resonance was measured over a 10 minute 
period yielding a variation of ± 0.1nm. The FOM value for this sensing platform is 
reasonably good and has a typical mid-range value compared to other sensing systems [10, 
17, 33–37]. The optical strength variation produced an index intensity sensitivity of ΔΙ/Δn = 
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2.7 × 103 and yielded a resolution of 1.0 × 10−4 with a FOM of 97, which is less than was 
obtained for wavelength interrogation. Whilst the overall index sensitivity is very high the 
spectral features are relatively broad thus compromising the overall detection limit. The 
spectral sensitivities quoted above are typical of these devices, but there are variations. The 
spectral broadness of the surface plasmons and spectral characteristics are a function of the 
variation of the nanowires’ shapes, sizes and geometries, which can be improved and 
standardised through refining the fabrication technique. Figure 5(d) shows a typical 
transmission spectrum following immobilisation of the thrombin aptamer on the surface of 
the device when submerged in buffer solution. It is useful to estimate the index spectral 
sensitivity of the aptamer coated sensing platform for the reader to make comparisons. To 
achieve this, without compromising or corrupting the performance of the aptamer coated 
sensing platform with additional submersions into standard refractive index solutions, we 
used existing data from before the immobilisation of the thrombin aptamer, in particular the 
refractive index spectral sensitivity data given in Fig. 5(b) that were obtained at the 
maximum excitation response for polarisation for each index solution. If we account for the 
measured maximised excitation of LSPR spectral location and assuming that the spectral 
sensitivity as a function of index continues with the same behavior at longer wavelengths, 
shown in Fig. 5(b), it is estimated that the wavelength spectral sensitivity is approximately 
3.4 × 104 nm/ RIU, leading to a conservative detection limit of 2.0 × 10−6 with a F.O.M. of 
330 in the aqueous index regime for the sensing platform immobilised with the thrombin 
aptamer. These results are the highest index spectral sensitivities reported in the literature 
[23–25] and amongst the highest index resolutions [23–25]. 
3.2 Detection of thrombin 
Thrombin solutions ranging from concentrations of 5 aM to 1 µM were prepared on ice and 
then examined in two formats. Purified thrombin was first assayed in static buffer solution in 
the apparatus illustrated in Figs. 1a and 1b, which demonstrated clear detection of thrombin 
down to 1 nM concentration, Figs. 6(a) and 6(b). Thrombin was also detected within bovine 
serum albumin (BSA) at a concentration of 4.5% w/v dissolved in a 50 mM Tris buffer 
solution (pH 7.4), in a flow cell as illustrated in Fig. 2(b)c. In this solution format, which 
aims to simulate human samples more closely, thrombin was detected at a 100 pM 
concentration. Moreover, in the flow-cell format, both association and dissociation of 
thrombin to the aptamer are visualized, Figs. 6(c) and 6(d). 
Figure 6(a) shows the overall wavelength shift with a graphical axis break to show the 
finer detail of the wavelength variation as a result of the various concentrations of thrombin 
in the 50 mM Tris buffer solution (pH 7.4). Figure 6(b) shows the change in optical strength 
at the central wavelength of the SPR spectral feature: as the concentrations increase the 
overall power increases from a baseline of −4.8dB. We note that we neglected to include the 
initial optical strength of the plasmon resonance due to the fact we wanted to show clearly the 
changes in optical strength due to the differing concentrations of thrombin. Inspecting Fig. 
6(a) it is noticeable that initial injections lead to a significant red-shift owing to the physical 
effects of mixing, however, once equilibrium has been reached, the greater the concentration 
of thrombin, the larger the blue-shift of the wavelength. This mixing effect can be seen in the 
transition period between the solutions with different concentrations. The change in optical 
strength of the resonance is more distinguishable than the wavelength changes, which prove 
to be relatively small. However, the latter are absolute measurements, whereas the optical 
strength can be corrupted by transient attenuation losses, such as fibre bending. 
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Fig. 6. Performance of the Au-SiO2-Ge/fibre coated aptamer device in the detection of 
thrombin. Parts (a) & (b) show wavelength shift and optical strength at the central wavelength 
responses respectively, in a fixed volume of static buffer, as a function of time, in response to 
thrombin concentrations over three orders of magnitude (1 nM → 1 µM) where thrombin was 
introduced at approximately 800 seconds. Parts (c) and (d) show similar results for two 
concentrations of thrombin in a flow cell with constant flow rate of 5 μl/min, using a Tris 
Buffer solution with a thrombin concentration of 100 nM (─) and 100 pM (─), with injections 
of buffer / buffer/thrombin mix as indicated. 
Flow experiments were conducted with various concentrations of thrombin using flow 
rates of 5 μl/min. Figure 6(c) and 6(d) illustrate typical association and dissociation of the 
thrombin (examples are 100 pM and 100nM) with aptamers immobilised on the surface of 
the optical sensor. 
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We observe that with these devices the LSP resonances are tunable over a very large 
wavelength range, as shown in Fig. 4(a). This also means the spectral characteristics (i.e. 
wavelength shift, spectral broadness and optical strength) and spectral sensitivity are very 
much dependent upon the spectral location of the LSP resonance through the material 
dependent dispersion characteristics [13, 16, 23]. The dispersion relationship can result in 
blue or red wavelength shifts as a function of the surrounding refractive index and an 
increase or decrease in the optical strength of the resonance. This is illustrated in Fig. 6, with 
Fig. 6(a) and 6(b) having a resonance at a wavelength close to 1353nm and producing blue 
wavelength shifts with increasing concentration whilst Fig. 6(c) and 6(d) have a resonance 
near 1423nm and produce a red wavelength shift. 
For the range of concentrations used there appears to be a demarcation from conventional 
equilibrium response with time at concentrations of about 100 pM and below. This can be 
seen in the association and dissociation time response curves shown in Figs. 6(c) and 6(d) 
with the lower concentration starting to show an unusual characteristic curve with additional 
smaller features appearing on the curves and what appears to be increasing variance at the 
steady state condition for this reaction. This behaviour is further illustrated in Fig. 7, showing 
the binding time response curve for a concentration of 50 aM. 
The detection limit of these devices was then tested with a series of experiments with 
different sensors exposed to ultra-low concentrations of thrombin in 50 mM Tris buffer 
solution (pH 7.4) - ranging from 5 aM to 1 pM concentrations in static format (Fig. 1b). A 
summary of three typical sensors’ spectral response to various concentrations of thrombin are 
shown in Figs. 7(a) and 7(b). Meanwhile, the time response of one of the devices at one of 
the lower concentrations (50 aM) is shown in Figs. 7(c) and 7(d). 
These three typical fibre devices were employed to take measurements over the 
concentration range. There appears to be a log-linear relationship between thrombin 
concentration and both wavelength shift and change in optical strength Figs. 7(a) and 7(b), 
albeit that the correlation is closest between thrombin concentration and change in optical 
strength. These data sets demonstrate consistent behaviour of this sensing platform. 
Interestingly, the response times (estimated to be the time taken for the trend of the response 
of the system to settle) of these equilibriums for different concentration solutions do not have 
a linear relationship with concentration, Fig. 7(e). Closer inspection of Fig. 7(e) shows that at 
approximately 100 pico-molar concentration there seems to be a change in the relationship of 
settling/incubation time to concentration; which is further explored in the discussion. 
However, the change in wavelength demonstrates greater resolution over the log-linear range 
inasmuch as the response to attomolar solutions is clearly visible in terms of wavelength 
shift, Fig. 7(a), but barely discernable in terms of change in optical strength, Fig. 7(b). 
Nevertheless, by adjusting the scale, binding between 50 aM thrombin and the immobilised 
aptamer is detectable by either measurement method, Figs. 7(c) and 7(d). This is particularly 
notable, since a concentration of 50 aM is equivalent to approximately 30 molecules of 
thrombin per µl of solution. 
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Fig. 7. Spectral sensitivity of aptamer-coated, static, multilayered SPR fibre devices (Au-SiO2-
Ge/fibre). (a) Change in optical coupling strength as a function of thrombin concentration. (b) 
Magnitude of wavelength change as a function of thrombin concentration. In parts a & b, , 
, and  represent measurements made with three different devices. (c) Wavelength change
and (d) Change in optical strength as a function of time after submersion in a static cell 
containing 50 aM thrombin (e) Estimation of the settling/incubation times of the binding 
reaction as a function of thrombin concentration. 
To assist in the understanding of the device, concentration-response curves are shown in 
Fig. 8 for both change in wavelength and optical strength of the LSP resonance in the 
transmission spectra. We found that the devices had a saturation concentration of 36μM and 
produced a maximum wavelength shift of 9.6nm and 3.2dB change in optical strength. The 
Hill coefficient for equilibrium was determined for both the optical strength change and 
wavelength shift using the standard graphical approach [37] and yields nHintensity = 0.229 and 
nHwavelength = 0.124, respectively, indicating negatively cooperative binding; once the target 
molecule is attached to the binding enzyme/chemical, the affinity for other target molecules 
decreases. 
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Fig. 8. The concentration-response curves of a (Au-SiO2-Ge/fibre) device based upon (a) 
wavelength shift and (b) optical strength change. 
Figure 8 yields half maximal effective concentration [38] (EC50) of 14 pMolar and 96 
pMolar for wavelength and optical strength, respectively. There are several approaches to 
estimate the limit of detection of this sensing platform. The detection limit can be estimated 
from the response with solutions at concentrations of 50aM and 5aM of thrombin in buffer; 
these two solutions produced wavelength shifts of 0.83nm and 0.43nm, respectively. There is 
a further complication associated with the measurement errors due to the increasing 
stochastic nature of the response of the system at these ultra-low concentrations, which can 
produce misleading results. A second approach is to use the EC10 value to yield an estimate 
of detection [38] using ( ) 50100
Hn
A
AEC ECA
−
 =  − 
, where A is the desired effective 
concentration and nH is the Hill coefficient (determined experimentally). Thus the EC10 point 
is 96aM and 68fM for wavelength and optical strength, respectively. We expect this 
difference due to the fact that the physical mechanism that governs the coupling strength to 
the surface plasmon is different to that involved in the phase matching condition [13, 15, 17, 
22] leading to different concentration-response curves.
Furthermore, another performance attribute of interest is the surface coverage resolution,
which is the minimum identifiable valid change of molecular mass captured by the 
recognition molecule. The coverage can be defined [39] as ( ) ( )Γ Δ Δ Δ
N h
n
n c
σσ λ= ∆⋅
where σN is the associated noise within the result (0.24nm), h is the thickness of the layer that 
has the refractive index change associated with the aptamer molecule (assumed here to be of 
the order of the size of the thrombin molecule ~5nm) and Δ
n
c
∆  is the volume refractive 
index increment of the molecular concentration, estimated to be about 0.18 cm3/g (DNA or 
BSA [39, 40]) leading to 0.2pg/mm2. This result again is amongst the highest from an optical 
sensing platforms reported in the literature [22–25, 41]. 
Detection limits of the flow device were then examined. The binding flow experiments 
were performed using thrombin in 0.6 mM (4.5% w/v) bovine serum albumin (BSA) / 50 
mM Tris-HCl pH 7.4. As can be seen in Figs. 9(a) and 9(b), BSA alone gave a consistent 
response both in terms of wavelength and optical strength, even after regeneration. However, 
detection of 10 nM thrombin in the presence of 4.5% (w/v) BSA is demonstrated far more 
clearly when examining wavelength shift, Fig. 9(a), circled in red, than when examining 
optical strength, Fig. 9(b), red circle. Higher sensitivity from observing wavelength shift is 
here more pronounced but nevertheless consistent with data observed in the static format, 
Fig. 7. 
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Fig. 9. The spectral response of an SPR (Au-SiO2-Ge/fibre) device with an immobilised 
thrombin aptamer on its surface in the sample flow cell format, with a constant flow rate of 
5μl/min. Wavelength shift (a) and change in the optical strength (b) as a function of time. The 
sensor was initially washed with a 4.5% (w/v) BSA in Tris-HCl pH 7.4, then regenerated with 
4 M NaCl, followed by second BSA wash. Thrombin (10 nM) in a 4.5% (w/v) BSA in Tris-
HCl pH 7.4 was introduced at 1800 s, which was followed by another regeneration in 4 M 
NaCl and a final BSA wash. 
One of the benefits of using an aptamer as the detecting molecule is that as single 
stranded DNA, it can also bind to its reverse complement. We therefore decided to examine 
both the specificity and sensitivity of the aptamer in the flow cell by examining the 
interaction with both complementary and non-complementary DNA sequences [30]. Figure 
10 demonstrates ready detection of complementary DNA at a 100 pM concentration, with no 
detectable signal generated by a non-complementary sequence of similar length. 
Fig. 10. Detection of hybridization between the DNA probe and both complementary and non-
complementary single-stranded DNA sequences. The flow rate was 5 µl/min. The cell was 
first washed with buffer (300 mM NaCl, 20 mM Na2HPO4, 0.1 mM EDTA, 0.05% TWEEN® 
20, pH 7.4). Non-complementary DNA was then introduced in the same buffer solution, 
followed by another buffer wash and then introduction of 100 pM complementary DNA, again 
in the same buffer. 
4. Discussion
Inspecting all the experimental results including the examples shown in Figs. 4 and 5 over the 
range of concentrations used of thrombin and estimating their incubation times for each 
experiment, we observe times that are significantly smaller than the times predicted by 
conventional models based upon diffusion-limited capture for equilibrium reactions [40]. 
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There is preceding literature that addresses this discrepancy [42–44]; the classical approach 
of modeling yields the mean incubation time, whilst experimental observations reveal the 
minimum detectable incubation time. It has been shown [43–45] for any sensor that the 
fundamental limit of detection for concentration under sufficiently long incubation times in a 
diffusion limited regime is given by a scaling relationship 0 ~D
M
avg Dt kρ , where tavg is the 
average or mean incubation time of the reaction, ρ0 is the initial concentration, MD and kD are 
sensor-dimensionality dependent constants. These two constants have been studied [42] for 
various surface morphologies and for a nanowire geometry MD ∼1 and 0Dk D
= s
N a
, where Ns 
is the minimum number of molecules needed to be captured for detection, D is the diffusion 
coefficient of the molecules and a0 is the radius of the nanowires which in our case is about 
30nm. Considering the conventional diffusion limit for an equilibrium, the diffusion 
coefficient can be calculated using the approach given in the literature [44]. We obtain a kD 
value of ~8.091 × 10−10 leading to 8.091 × 107 s for the average incubation time of the 
reaction with a concentration of 10 aM for a volume of 1mm3 (approximately 30000 
molecules of thrombin), which is approaching 937 days. 
Furthermore, at approximately 100 pico-molar concentrations there appears to be a 
distinct demarcation between the conventional equilibrium kinetic behaviour and a more 
stochastic kinetic nature. This can be seen by making a comparison of the general temporal 
response of the binding reaction for solutions with thrombin concentrations of 100nM and 
100pM shown in Figs. 6(c) and 6(d). The response of the optical system to 100pM 
concentration solution starts to show fluctuations from a typical equilibrium time response, 
with more pronounced examples being shown in Figs. 7(c) and 7(d). This may be expected 
considering that the target thrombin molecule numbers are small in the volume of solution, 
and thus individual molecules can be considered to be acting independently from other 
thrombin molecules. 
Assuming that the red wavelength shift in Fig. 6(a) is due to buffer ingression into the 
aptamer coating we can estimate the spectral and intensity sensitivity of the SPR device from 
Fig. 6(b). By working to the intensity detection limit associated with this interrogation 
scheme (0.1dB) and using linear regression with the experimental data, the following 
empirical relationships for strength and wavelength change with concentration were obtained: 
ΔΙ(dB) = 0.26ln(Concen) + 1.82 and Δλ(nm) = 0.83ln(Concen) + 7.15, where Concen is the 
molar concentration of thrombin. These formulae permit the estimation of a minimum 
detectable concentration of thrombin in the buffer solution, which is approximately 5 aM; 
this was confirmed using thrombin concentrations down to 5aM, where no spectral changes 
were observed experimentally. The caveat here is that we are assuming the device has the 
same logarithmic spectral behaviour found at higher concentrations at the lower 
concentrations down to the limit of detection. 
Comparing these results with those given in [46] (detection limits in the order of 1nM), 
this SPR device shows excellent detection sensitivity. Using the above data and the pseudo 
first-order kinetics approximation for the reaction of the aptamer and the thrombin, we 
estimated the association rate constant and the dissociation rate constant to be 1.06 × 106 ± 
0.05 × 106 M−1s−1 and 0.24 ± 0.03 s−1 respectively, which leads to an equilibrium 
(association) constant of 4.28 × 106 ± 0.07 × 106 M−1. These results compare well with the 
rate constant given in the literature [47–50] at similar concentrations. By comparison with 
our system, other approaches that make use of enhancement techniques may be compromised 
by the inclusion of additional particles to support the plasmons [22]. Similarly the approaches 
that make use of labelling also require the presence of additional species, e.g. fluorophores 
[1]. 
The demonstration of thrombin detection in a 4.5% (w/v) BSA protein in binding buffer 
(50mM Tris 140mM NaCl 1mM MgCl2) pH 7.4, given in Fig. 9 shows that BSA protein can 
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be distinguished from the thrombin and that the thrombin has preferential interaction over the 
BSA. The authors do acknowledge that in real world applications using blood plasma there 
are a large number of other complex compounds and proteins present and nonspecific co-
present binding cannot at this stage be ruled out. Nevertheless this particular test with 4.5% 
(w/v) BSA with thrombin is a step closer to the composition of blood, where the albumin (in 
humans it is human serum albumin) is the most common protein. Due to the concentration 
levels of the albumin protein it may adhere to the surface of the sensor and thus act as a 
blocker for the attachment of the thrombin to the aptamer. The detection limit of thrombin in 
the BSA solution was obtained by determining the experimentally observed wavelength shift 
as a function of thrombin concentration and using the spectral resolution of the resonance 
itself [33]; this yielded approximately 0.1nM, which is in the initial concentration range in 
the lag time of the typical human thrombin generation curve [51–56] (HTGC) resulting from 
samples taken from patients. Furthermore these sensing devices can also be used over the 
complete concentration range of a HTGC; at the peak thrombin level and through the 
endogenous thrombin potential [52–54]. 
The average time interval between successive measurements varied for each experiment 
from 2 seconds to 6 seconds. The OSA covered an extended spectral range to observe as 
much of the transmission feature of the sensing platform as possible, up to approximately 
400nm. The measurement time can be dramatically reduced to sub-second if required by 
reducing the spectral scanning range. The 3dB bandwidth of the localised surface plasmon 
excitation in the transmission spectrum varies from 80 nm to 200 nm (typical transmission 
spectrum from a device is shown in Fig. 5(d)). The interrogation scheme could be changed to 
other techniques that have higher data acquisition rates. For existing biosensing systems, the 
response time becomes excessively long for femtomolar and attomolar concentrations, 
ranging upwards from 300 seconds to as much as 105 seconds [19]. Response time is 
important for a significant number of label-free clinical applications [29,46] and these times 
mean that the monitoring of real-time kinetics is not possible. The detection technique 
presented here yields continuous meaningful experimental data on an acquisition rate of 
approximately a second or less at femtomolar and attomolar concentrations and thus true 
binding kinetic data can be obtained. 
We can compare our performance against other thrombin sensing technologies, for 
example the Biacore system. That has a detection limit in concentration of around 10 pM 
[54], which is six orders of magnitude less sensitive than ours and yet has higher sensitivity 
compared to approaches such as electrochemical detection, where the detection limit is 
approximately 0.4nM [56], or other methods that employ a surface plasmon resonance, which 
yield 5nM [45]. Recently an SPR device with an enzymatic amplification approach [48] 
yielded a limit of 500 fM, this still represents several orders poorer resolution than the SPR 
device reported here. There are several approaches to the detection of thrombin with 
aptamers and most of these techniques have a limit of detection of approximately 1 to 10nM 
[49]; this again is significantly less sensitive. Secondly comparing this scheme of detection to 
the conventional methods of measuring thrombin and associated coagulants: instruments with 
similar performance are financially expensive and not compatible with remote, real-time 
operation. The presented scheme has the potential to be made relatively cheap and compact 
whilst still offering similar or better performance to the more conventional systems [55]. It 
must be stated that some of the detection schemes use small solution volumes, comparable to 
the volume used in this series of experiments, thus it’s reasonable to quote the total number 
of molecules/particles that are being detected, which is 30000. This may appear to be a large 
number compared to other schemes but a better comparison is the sensing coverage [34] for 
this particular molecule (thrombin), which is estimated be to 0.2pg/mm2 that is amongst the 
highest from an optical sensing platforms reported in the literature [23–25, 39]. 
In conclusion, we have demonstrated a new opto-bio-sensing platform based upon 
aptamers immobilised onto an optical sensing structure that utilises infrared localised surface 
Vol. 25, No. 1 | 9 Jan 2017 | OPTICS EXPRESS 57 
plasmons to provide a detection limit of a few attomolar concentrations of thrombin in a 
sodium phosphate buffer solution. This significantly outperforms other types of sensing 
platforms including fibre optic, surface plasmon or electrochemical thrombin sensors by four 
orders of magnitude. Our demonstrated approach offers advantages, for example the ability to 
evaluate variations in the picomolar range, which is inaccessible with classical techniques. In 
addition the performance of the device in the presence of non-specific protein provides an 
early indication that the sensitivity and specificity of the device may be maintained in a 
realistic environment. 
Moreover, we may compare this optical sensing scheme to other fibre optical sensing 
methods, where the best reported performance to date is limited to detection levels of 500 fM 
[48]. This limit of a few hundred fM has been echoed in a recent review paper [48]. Making a 
comparison to the other detection techniques [56, 57] the opto-bio-sensing platform offers the 
opportunity to collect real-time data for kinetic studies at ultra-low concentrations in the 
femtomolar and attomolar ranges. The range of biological and chemical molecules for which 
high affinity aptamers have been developed is extensive and aptamer development continues 
apace. The successful employment of the well characterised 15 mer thrombin binding 
aptamer to our sensing device suggests our technology also has the potential to detect ultra-
low concentrations of other chemicals, taking advantage of the so-called “lock-and-key” 
relationship between aptamers and their binding partners [49]. Furthermore, the chemical 
selectivity test was performed with another compound, a DNA probe, which provided 
evidence that this optical platform reflects the affinity of the binding molecule to the target 
molecule. 
The combination of this next generation localised surface plasmon sensing scheme with 
aptameric functionalised coatings offers great potential for remote sensing [55], providing as 
it does both high sensitivity and selectivity, coupled with a small physical footprint and low 
loss fibre connecting leads. In this regard the environmental application to remote sensing 
arrays for the detection of ultra-low concentrations of harmful substances is quite apparent. 
For example, our system has the potential to readily target estrogenic compounds, herbicides, 
pesticides, and industrial by-products that persist especially in the agricultural environment, 
which can cause infertility, deformed reproductive organs and other biological defects in 
extreme cases [50]. 
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